The board met in Croatia in April and in December in Copenhagen, relevant minutes have been circulated.
Housekeeping rules have been created and must be approved at this occasion.
It was decided to include our JMA as member with voting rights – since the bylaws only allows for 6 members in the board, we so far decided to include our JMA as an Adjunct Member. This item should also be discussed.
Two Task forces are currently working: one on APT chaired by Kristiina Turjanmaa and a second one has just been approved by ExCom, namely on Late phase reactions in AD, chaired by Thomas Werfel. Discussion with Rudolf Valenta on presenting the APT position paper in Vienna is undergoing.
The Vienna program has adopted most of our decisions, including a session together with ESCD.
The two latter may be switched.
Regarding the process of evaluating abstracts or the congresses, it has been agreed between Pediatric and Dermatology Sections, that we evaluate abstracts on dermatological topics together.
- Urticaria Consensus Meeting October, Berlin
- Newsletter June 2005
- Planning and approval for Food Allergy Course april 2006, together with Ped Section
- Practall – a Joint Initiative between EAACI and AAAAI on the topic AD. Two more are planned, Anaphylaxis and Pediatric Asthma.
- For 2006, 2-3 summer schools EAACI/GA2LEN are scheduled. One is already accepted in Oslo, two more are currently being evaluated. Application for summer schools must be filed in during the next two months.
Dermatology section should propose a summer school for 2006 or 2007 (preferentially). Topic should be decided here.
Unsolved issues to be addressed in the next period:
- The number of members with voting rights in our Section is stable at a low level (280). ENT is closing in on us and we need to find ways of increasing the number of our core members. This can only be done internally by taking members from other sections - an unwise solution: Instead we should attract members from outside EAACI and talks with EADV and ESCD has been initiated and will be substantiated in the near future.
- Our JMA, Ulrike Raap has been nominated JMA Chair and will represent the JMA in ExCom. She has been replaced by Dr Elena Borzova, from Russia. A warm welcome to you. We must decide whether our JMA is an ordinary member or an adjunct member. The work in ExCom has been interesting and sometimes hard – there are a lot of things to be learnt especially since there are several political issues to be aware of at and between the meetings. But our impact is increasing and we should strengthen our efforts in seeking influence there. Therefore I am willing to serve another period as chairman of our Section.
Carsten Bindslev-JensenLast updated: 14 July 2009
1 – Board
The board is elected according to the bylaws of the EAACI.
In addition, the JMA Dermatology representative is taken as an Adjunct Board Member with full responsibilities and voting rights. He/she will count as the 8th ordinary member of the board. The number of members present to make a formal decision is 4/8, single majority votes (e.g. 5/3) are required for decisions. Only members present at the meeting are allowed to be elected for their first period serving on the board.
2 – Section board meetings
Minimum twice per year: one at the EAACI congress, one at the Derm Section meeting. In years with no section meeting, the meeting should be held preferably at other congress, e.g. EADV. Extra meeting in case of urgent matters is possible if it is announced by the chairman one month in advance, unless all board members have unanimously accepted a prior meeting. Electronic communication, telephone conference may be used for intermediate decisions. Meetings are normally on invitation by the chairman, but any member of board can request on extra meetings or electronic/telephone conferences. In this case, a majority decision is required by e-mail in advance. Any extra meeting in person is subject to available funding.
Meetings are chaired by the chairman, in unexpected absence by the secretary.
3 – Daily routine
The daily routine is run by the Chairmen and Secretary, all communication should be preferably by e-mail and all board members will be copied in.
4 – Section activities
At the EAACI Congress, the section should ensure a balanced programme regarding dermatological contents in allergy.
EAACI Derm section meetings should be held preferably annually, external additional funding should be looked for every 2-3 years, joint meetings with other sections are encouraged.
Joint sessions at international or national dermatology congresses, esp. EADV, are desirable.
The internet should provide information about meetings, protocols of board meetings, task forces, guidelines, activities (responsible: secretary).
Guidelines on relevant subjects should be prepared by the section, if possible of highest level. Guidelines prepared by other sections or the EAACI ExCom dealing with dermatological topics in allergy should be co-authored by the Derm Section.
4.4 Task forces
In topics of dermatology where special attention is needed, the Derm Section should be putting up EAACI Task Forces.
4.5 Other activities
All other activities which are in the interest of the aims of the EAACI and dermatology in allergy, e.g. contact with patient organisation, are encouraged, but usually not extra-funded.
5 – Collaboration with other institutions
Collaboration with other institutions, especially GA²LEN, is strongly encouraged.
6 – Financial affairs
Both, the Chairman and the Secretary, are responsible for the correct spending of the budget, all decisions on higher sums of spending, esp. for section meetings, need to be approved by the board.Last updated: 14 July 2009
This resource is for EAACI members only. To log-in use your EAACI username & password. If you are not a member of the EAACI, click here to join us.Last updated: 20 April 2010
1. Hot topics in the Dermatology Section
Allergic contact dermatitis in children
2. New books published within the last two years
Urticaria and angioedema
Editors: Torsten Zuberbier, Clive Grattan & Marcus Maurer (Springer).
Valuable resource for those interested in skin research! The book explores the he history, aetiopathogenesis and classification of urticaria, as well as providing in depth understanding of acute, chronic, dermographic and delayed pressure, heat and cold, solar, cholinergic, contact urticaria. The last part is devoted to the urticarial syndromes and autoinflammation, vasculitis and angioedema, therapy of urticaria, standard operating procedures and practical approaches. The book is written by leading experts in the field and provides a comprehensive update on every aspect of current management of urticaria.
3. Books in press
Editors: Jean Bolognia, Jozeph Jorizzo, Ronald Rapini
The ultimate goal of the book is for it to never make its way to the bookshelf because it is being used on a weekly, or perhaps even daily, basis. This book will function as a colleague, albeit a non-verbal one, who is easily approachable and possesses the necessary expertise to provide succinct, up-to date information that is both precise and practical.
4. The must read papers of the last 3-6 months
EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria.
Konstantinou G.N., Asero R., Ferrer M., Knol E.F., Maurer M., Raap U., Schmid-Grendelmeier P., Skol P.S., Grattan C.E.
Allergy 2013, 68(1):27-36.
European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives.
Valent P,, Arock M., Bonadonna P., Brockow K., Broesby-Olsen S., Escribano L., Gleixner K.V., Grattan C., Hadzijusufovic E., Hägglund H., Hermine O., Horny H.P., Kluin-Nelemans H.C., Maurer M., Niedoszytko M., Nedoszytko B., Nilsson G., Oude-Elberink H.N., Orfao A., Radia D., Reiter A., Siebenhaar F., Sotlar K., Sperr W.R., Triggiani M., Vandoormaal J.J., Várkonyi J., Yavuz S., Hartmann K.
Wien Klin Wochenschr 2012, 124;(23-24):807-814
How not to miss autoinflammatory diseases masquerading as urticaria
Krause K., Grattan C.E., Bindslev-Jensen C., Gattorno M., Kallinich T., de Koning H.D., Lachmann H.J., Lipsker D., Navarini A.A., Simon A., Traidl-Hoffmann C., Maurer M.
Allergy 2012, 67;12:1465-74
Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study
Krause K., Weller K., Stefaniak R., Wittkowski H., Altrichter S., Siebenhaar F., Zuberbier T., Maurer M.
Allergy 2012, 67;7:943-50.
A positive serum basophil histamine release assay is a marker for ciclosporin-responsiveness in patients with chronic spontaneous urticaria
Iqbal K., Bhargava K., Skov PS., Falkencrone S., Grattan C.
Clinical and Translational Allergy 2012, 1;2(1):19
Marrouche N., Grattan C.
Current Opinion in Allergy and Clinical Immunology 2012, 12(5):485-90
Mutational spectrum and geno-phenotype correlation in Chinese families with Hereditary Angioedema
Xu Y., Zhi X., Yin J., Wang L., Wen L.P., Gu J.Q., Guan K., Craig T., Zhang H.Y.
Allergy 2012, 67(11):1430-6
Anaphylaxis in an emergency setting – elicitors, therapy and incidence of severe allergic reactions
Beyer K., Eckermann O., Hompes S., Grabenhenrich L. and Worm M.
Allergy 2012, 67(11):1451-6
IgE detection to α/β/γ-gliadin and its clinical relevance in wheat-dependent exercise-induced anaphylaxis
Hofmann S.C., Fischer J., Eriksson C., Bengtsson Gref C., Biedermann T., Jakob T.
Allergy 2012, 67(11):1457-60
Attenuated Bordetella pertussis BPZE1 protects against allergic airway inflammation and contact dermatitis in mouse models
Li R., Cheng C., Chong C.Z., Lim A.R., Goh Y.F., Locht C., KemenyD.M., Angeli V., W.S. Wong, Alonso S.
Allergy 2012, 67(10):1250-8
Successful use of omalizumab in an inadequately controlled type 2 diabetic patient with severe insulin allergy.
Cavelti-Weder C., Muggli B., Keller C., Babians-Brunner A., Biason-Lauber A., Donath M.Y., Schmid-Grendelmeier P.
Diabetes Care 2012, 35(6):e41
Development and construct validation of the angioedema quality of life questionnaire
Weller K., Groffik A., Magerl M., Tohme N., Martus P., Krause K., Metz M., Staubach P., Maurer M.
Allergy 2012, 67(10):1289-98
5. Current international projects
Published Task Forces
Profiling Urticaria for the Identification of Subtypes (PURIST)
6. Related resources
1. Is it time for clinicians to relate genotypes to phenotypes?
2. Skin barrier function in the development of allergy
3. Skin barrier function in the development of allergy
4. Common allergic diseases in the elderly
Postgraduate Course: Practical issues in contact allergy and urticaria
31st EAACI Congress, Geneva, Switzerland on 16th of June, 2012
Antti Lauerma (Finland): Expert tips for patch testing
Radoslaw Spiewak (Poland): Testing for photoallergy
Jurgen Grabbe (Switzerland): Contact urticarial
Markus Magerl (Germany): Physical challenge testing
Urlike Raap (Germany): Skin testing in urticaria
Symposium - Atopic dermatitis: the wider picture
31st EAACI Congress, Geneva, Switzerland on 17th of June, 2012
Edward Knol (The Netherlands): Atopic dermatitis: beyond the skin and into the gut
Graham Ogg (UK): Specific immunotherapy in atopic dermatitis
Thomas Bieber (Germany): Off-label drugs for atopic dermatitis
Symposium - Understanding urticaria
31st EAACI Congress, Geneva, Switzerland on 18th of June, 2012
Clive Grattan (UK): Tracking down a cause of urticaria
Peter Schmid-Grendelmeier (Switzerland): Germs and worms in urticaria
Riccardo Asero (Italy): Aggravating factors in chronic urticaria
Symposium - New trends in allergy research in Russia
31st EAACI Congress, Geneva, Switzerland on 18th of June, 2012
Ludmila Ogorodova (Russian Federation): Epidemiology of food allergy in Russia
Musa Khaitov (Russian Federation): The interaction of RSV and epithelial cells in the lung
Elena Borzova (Russian Federation): The role of autoantibodies in chronic urticarial
Symposium - Food allergy and atopic dermatitis: a tale of two epithelia
31st EAACI Congress, Geneva, Switzerland on 19th of June, 2012
Aziz Sheikh (UK): Epidemiological evidence implicating defects in skin barrier to sensitization to food allergens
Thomas Werfel (Germany): Classical and pollen-related food allergies in patients with topic dermatitis – the impact of late eczematous reactions
Suzanne Pasmans (The Netherlands): When to use elimination diets in children with atopic dermatitis?
Skin Allergy Meeting
Berlin, Germany, 29 November to 1 December 2012
Thursday, 29 November 2012
Ana Giménez-Arnau - Allergic contact dermatitis
Werner Aberer - Non-Hereditary Angioedema
Ilaria Baiardini - Quality of life instruments for daily practice
Carsten Bindslev-Jensen - Food Allergy
Gino Vena - Aquatic dermatoses
Michihiro Hide - The role of sweat in skin disease - beyond hyperhidrosis
Romi Saini - The role of basophils in skin allergies
Friday, 30 November 2012
Martin Metz - Itch
Torsten Zuberbier - Interactive discussion with experts on international approaches in allergology
Margitta Worm - Anaphylaxis
Torsten Zuberbier - Atopic Dermatitis
Frank Siebenhaar - Mastocytosis
Karoline Krause - Autoinflammatory syndromes
Konrad Bork - Hereditary Angioedema
Martin Church - Role of histamine in skin physiology and allergies
Saturday, 1 December 2012
Peter Schmid-Grendelmeier - Tropical and travelers' dermatoses
Marcus Maurer – Urticaria
Clive Grattan - QUIZ - Allergic or not allergic
Can you spot the difference (and win a prize)?
4th Urticaria consensus meeting
Berlin, Germany, November 28-29, 2012
This is a 4 yearly meeting prepared by the EAACI Dermatology Section and GA2LEN for the review of the current international guidelines on the classification, pathogenesis and management of urticaria.
7. Upcoming events
* Skin Allergy Club
Zurich, Switzerland, April 20-21, 2013
* EAACI – WAO World Allergy & Asthma Congress
Milan, Italy, 22-26 June, 2013Last updated: 28 November 2014